相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association between ultrasound quality and test performance for HCC surveillance in patients with cirrhosis: a retrospective cohort study
Nicolas Chong et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2022)
Associations of Ultrasound LI-RADS Visualization Score With Examination, Sonographer, and Radiologist Factors: Retrospective Assessment in Over 10,000 Examinations
David T. Fetzer et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2022)
Overdiagnosis of hepatocellular carcinoma: Prevented by guidelines?
Nicole E. Rich et al.
HEPATOLOGY (2022)
GALAD demonstrates high sensitivity for HCC surveillance in a cohort of patients with cirrhosis
Amit G. Singal et al.
HEPATOLOGY (2022)
HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: A meta-analysis
Amit G. Singal et al.
JOURNAL OF HEPATOLOGY (2022)
Patient Preferences for Hepatocellular Carcinoma Surveillance Parameters
Sean A. Woolen et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)
Doylestown Plus and GALAD Demonstrate High Sensitivity for HCC Detection in Patients With Cirrhosis
Amit G. Singal et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)
Dynamic Changes in Ultrasound Quality for Hepatocellular Carcinoma Screening in Patients With Cirrhosis
Haley Schoenberger et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)
Decreasing Trend of Serum α-Fetoprotein Level in Hepatocellular Carcinoma
Aarshi Vipani et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)
Validation of a Novel Multitarget Blood Test Shows High Sensitivity to Detect Early Stage Hepatocellular Carcinoma
Naga P. Chalasani et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)
A multi-analyte cell-free DNA-based blood test for early detection of hepatocellular carcinoma
Nan Lin et al.
HEPATOLOGY COMMUNICATIONS (2022)
Multimarker Panels for Detection of Early Stage Hepatocellular Carcinoma: A Prospective, Multicenter, Case-Control Study
Teerha Piratvisuth et al.
HEPATOLOGY COMMUNICATIONS (2022)
Use of Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis: A Systematic Review and Meta-Analysis
Erin Wolf et al.
HEPATOLOGY (2021)
Patient-Reported Barriers Are Associated With Receipt of Hepatocellular Carcinoma Surveillance in a Multicenter Cohort of Patients With Cirrhosis
Amit G. Singal et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
Benefits and Harms of Hepatocellular Carcinoma Surveillance in a Prospective Cohort of Patients With Cirrhosis
Amit G. Singal et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
Outcome of Hepatocellular Carcinoma Detected During Surveillance: Comparing USA and Japan
Hidenori Toyoda et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
Predictors of five-year survival among patients with hepatocellular carcinoma in the United States: an analysis of SEER-Medicare
Xiaotao Zhang et al.
CANCER CAUSES & CONTROL (2021)
International Liver Cancer Association (ILCA) White Paper on Biomarker Development for Hepatocellular Carcinoma
Amit G. Singal et al.
GASTROENTEROLOGY (2021)
Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement
Karina W. Davidson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Diagnostic and Therapeutic Delays in Patients With Hepatocellular Carcinoma
Ashwin Rao et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)
A blood-based prognostic liver secretome signature and long-term hepatocellular carcinoma risk in advanced liver fibrosis
Naoto Fujiwara et al.
MED (2021)
Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis
Andrew M. Moon et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis
Jan Best et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Hepatocellular Carcinoma Demonstrates Heterogeneous Growth Patterns in a Multicenter Cohort of Patients With Cirrhosis
Nicole E. Rich et al.
HEPATOLOGY (2020)
Risk Factors for Cirrhosis in Contemporary Hepatology Practices-Findings From the Texas Hepatocellular Carcinoma Consortium Cohort
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2020)
Diverse effects of hepatic steatosis on fibrosis progression and functional cure in virologically quiescent chronic hepatitis B
Lung-Yi Mak et al.
JOURNAL OF HEPATOLOGY (2020)
Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates
Zobair Younossi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Primary Care Provider Practice Patterns and Barriers to Hepatocellular Carcinoma Surveillance
Okeefe L. Simmons et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Longitudinal Assessment of Three Serum Biomarkers to Detect Very Early-Stage Hepatocellular Carcinoma
Jonggi Choi et al.
HEPATOLOGY (2019)
Clinical performance of α-L-fucosidase for early detection of hepatocellular carcinoma
Hao Xing et al.
BIOMARKERS IN MEDICINE (2019)
Validation of the Hepatocellular Carcinoma Early Detection Screening (HES) Algorithm in a Cohort of Veterans With Cirrhosis
Nabihah Tayob et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Rationale and design of the Hepatocellular carcinoma Early Detection Strategy study: A multi-center longitudinal initiative of the National Cancer Institute's Early Detection Research Network
Kelly A. Borges et al.
CONTEMPORARY CLINICAL TRIALS (2019)
Frequency and Outcomes of Abnormal Imaging in Patients With Cirrhosis Enrolled in a Hepatocellular Carcinoma Surveillance Program
Monica A. Konerman et al.
LIVER TRANSPLANTATION (2019)
Design of the Texas Hepatocellular Carcinoma Consortium Cohort Study
Ziding Feng et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2019)
Hepatocellular carcinoma surveillance in the 21st century: Saving lives or causing harm?
Ibrahim A. Hanouneh et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2019)
Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis
Kristina Tzartzeva et al.
GASTROENTEROLOGY (2018)
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Jorge A. Marrero et al.
HEPATOLOGY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Diagnostic accuracy of SCCA and SCCA-IgM for hepatocellular carcinoma: A meta-analysis
Chang-Hai Liu et al.
LIVER INTERNATIONAL (2018)
Predictors of Ultrasound Failure to Detect Hepatocellular Carcinoma
Mariya L. Samoylova et al.
LIVER TRANSPLANTATION (2018)
Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease
Fasiha Kanwal et al.
GASTROENTEROLOGY (2018)
Osteopontin versus alpha-fetoprotein as a diagnostic marker for hepatocellular carcinoma: a meta-analysis
Tingting Sun et al.
ONCOTARGETS AND THERAPY (2018)
A Bayesian screening approach for hepatocellular carcinoma using multiple longitudinal biomarkers
Nabihah Tayob et al.
BIOMETRICS (2018)
Predictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosis
O. Simmons et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Identifying Barriers to Hepatocellular Carcinoma Surveillance in a National Sample of Patients With Cirrhosis
David S. Goldberg et al.
HEPATOLOGY (2017)
An Assessment of Benefits and Harms of Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis
Omair Atiq et al.
HEPATOLOGY (2017)
Patient-Reported Barriers Are Associated With Lower Hepatocellular Carcinoma Surveillance Rates in Patients With Cirrhosis
Sherean Farvardin et al.
HEPATOLOGY (2017)
Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma
Rui-hua Xu et al.
NATURE MATERIALS (2017)
Cost-Effectiveness of Risk Score-Stratified Hepatocellular Carcinoma Screening in Patients with Cirrhosis
Nicolas Goossens et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2017)
Improved Performance of Serum Alpha-Fetoprotein for Hepatocellular Carcinoma Diagnosis in HCV Cirrhosis with Normal Alanine Transaminase
Ju Dong Yang et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)
Impact of disease stage and aetiology on survival in hepatocellular carcinoma: implications for surveillance
Philip Johnson et al.
BRITISH JOURNAL OF CANCER (2017)
The Doylestown Algorithm: A Test to Improve the Performance of AFP in the Detection of Hepatocellular Carcinoma
Mengjun Wang et al.
CANCER PREVENTION RESEARCH (2016)
Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients
Sarah Berhane et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Diagnostic Performance of Alpha-Fetoprotein, Protein Induced by Vitamin K Absence, Osteopontin, Dickkopf-1 and Its Combinations for Hepatocellular Carcinoma
Eun Sun Jang et al.
PLOS ONE (2016)
Alpha-Fetoprotein Measurement Benefits Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis
Te-Sheng Chang et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Improved Surveillance for Hepatocellular Carcinoma With a Primary Care-Oriented Clinical Reminder
Lauren A. Beste et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Screening for Hepatocellular Carcinoma in Chronic Liver Disease A Systematic Review
Devan Kansagara et al.
ANNALS OF INTERNAL MEDICINE (2014)
Diagnosis Accuracy of Serum Glypican-3 in Patients with Hepatocellular Carcinoma: A Systematic Review with Meta-analysis
Xiaobo Jia et al.
ARCHIVES OF MEDICAL RESEARCH (2014)
The Detection of Hepatocellular Carcinoma Using a Prospectively Developed and Validated Model Based on Serological Biomarkers
Philip J. Johnson et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)
Hepatocellular Carcinoma Screening in Patients With Compensated Hepatitis C Virus (HCV)-Related Cirrhosis Aware of Their HCV Status Improves Survival: A Modeling Approach
Abbas Mourad et al.
HEPATOLOGY (2014)
High-sensitivity Lens culinaris agglutinin-reactive alpha-fetoprotein assay predicts early detection of hepatocellular carcinoma
Takashi Kumada et al.
JOURNAL OF GASTROENTEROLOGY (2014)
Diagnostic and prognostic role of SCCA-IgM serum levels in hepatocellular carcinoma (HCC)
Caterina Pozzan et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)
Multitarget Stool DNA Testing for Colorectal-Cancer Screening
Thomas F. Imperiale et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Comparison osteopontin vs AFP for the diagnosis of HCC: A meta-analysis
Hao-Guang Wan et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2014)
The Harms of Screening A Proposed Taxonomy and Application to Lung Cancer Screening
Russell P. Harris et al.
JAMA INTERNAL MEDICINE (2014)
Evaluation of Midkine as a Diagnostic Serum Biomarker in Hepatocellular Carcinoma
Wen-Wei Zhu et al.
CLINICAL CANCER RESEARCH (2013)
Improving Screening for Hepatocellular Carcinoma by Incorporating Data on Levels of α-Fetoprotein, Over Time
Elliot Lee et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Screening for Liver Cancer: The Rush to Judgment
Morris Sherman et al.
ANNALS OF INTERNAL MEDICINE (2012)
Golgi protein 73 versus alpha-fetoprotein as a biomarker for hepatocellular carcinoma: a diagnostic meta-analysis
Ying Zhou et al.
BMC CANCER (2012)
Identification of osteopontin as a novel marker for early hepatocellular carcinoma
Sufen Shang et al.
HEPATOLOGY (2012)
Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study
Qiujin Shen et al.
LANCET ONCOLOGY (2012)
Des-γ-Carboxy Prothrombin and α-Fetoprotein as Biomarkers for the Early Detection of Hepatocellular Carcinoma
Anna S. Lok et al.
GASTROENTEROLOGY (2010)
α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular Carcinoma
Jorge A. Marrero et al.
GASTROENTEROLOGY (2009)
Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (Hemoccult): An update
Paul Hewitson et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Benefits and harms of prostate-specific antigen screening for prostate cancer: An evidence update for the US preventive services task force
Kenneth Lin et al.
ANNALS OF INTERNAL MEDICINE (2008)
Utility and limitations of glypican-3 expression for the diagnosis of hepatocellular carcinoma at both ends of the differentiation spectrum
Nafis Shafizadeh et al.
MODERN PATHOLOGY (2008)
Etiology-dependent molecular mechanisms in human hepatocarcinogenesis
Christof Schlaeger et al.
HEPATOLOGY (2008)
Systematic review: The long-term effects of false-positive mammograms
Noel T. Brewer et al.
ANNALS OF INTERNAL MEDICINE (2007)
GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma
JA Marrero et al.
JOURNAL OF HEPATOLOGY (2005)
SCCA antigen combined with alpha-fetoprotein as serologic markers of HCC
G Giannelli et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Randomized controlled trial of screening for hepatocellular carcinoma
BH Zhang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2004)
AFP-L3: a new generation of tumor marker for hepatocellular carcinoma
D Li et al.
CLINICA CHIMICA ACTA (2001)
分享论文
